Associate Director - Biologics Operations – Lilly Medicine Foundry at Eli Lilly and Company

Lebanon, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Leadership experience in managing frontline leaders and operational resources in manufacturing, particularly biologics or GMP environments
Ability to build and promote a strong Safety and Quality culture
Expertise in ensuring regulatory compliance (e.g., Safety, Quality/cGMP, Environmental, Financial, Legal, HR)
Skills in lean principles and operational excellence
Capability to collaborate cross-functionally and integrate teams
Experience in setting objectives, development plans, training, and managing staff (Operations Leaders and Operators)
Resilience, creativity, and adaptability for dynamic startup phases (2025-2028)
Ability to attract, hire, and onboard top talent with the right attitude, curiosity, and learning agility

Responsibilities

Manage day-to-day manufacturing operations in the Biologics building and oversee operational resources for the execution team
Lead frontline leaders in the direct execution of manufacturing instructions (e.g., batch production records, SOPs) to safely and compliantly manufacture high-quality medicine
Serve as key integrator of the cross-functional team to drive safety, quality, and continuous improvement toward Operational Excellence
Build and promote a strong Safety and Quality culture; maintain a safe working environment
Ensure consistency of operations across shifts through active engagement on the production floor
Own the implementation of the change and improvement agenda, ensuring cross-functional support and integration
Set objectives and development plans for Operations staff, including Operations Leaders and Operators
Manage events, ensure appropriate communication, provide input, and approve investigations
Ensure team members are appropriately trained and that operating procedures and training materials are available and current
Support regulatory compliance and operational excellence through lean principles
Participate in development and delivery of medium- and long-term strategic direction for the site
Ensure Biologics operations remain compliant with all applicable regulatory requirements
Support site governance through participation, influence, and leadership in cross-functional meetings and initiatives
During startup phase (2025-2027), attract, hire, and onboard top talent to the Foundry team, establishing the right attitude, curiosity, and learning agility

Skills

Biologics Manufacturing

Operations Management

GMP

SOP

Batch Production

Quality Control

Safety Leadership

Continuous Improvement

Cross-Functional Leadership

Team Management

Manufacturing Execution

Operational Excellence

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free